06:23:18 EDT Sun 06 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
MedX Health Corp
Symbol MDX
Shares Issued 285,813,744
Close 2025-06-12 C$ 0.085
Market Cap C$ 24,294,168
Recent Sedar Documents

MedX Health hires Red Cloud for market-making services

2025-06-12 20:52 ET - News Release

Mr. Mike Druhan reports

MEDX ANNOUNCES THE ENGAGEMENT OF MARKET MAKER CONSULTANT

MedX Health Corp. has engaged Red Cloud Securities Inc. to provide market-making services to the company.

Pursuant to the agreement between Red Cloud and MedX, Red Cloud will be paid a monthly flat fee of $5,000, payable in advance in cash for the period from June 15, 2025, to Sept. 15, 2025, and continuing thereafter on a monthly basis. Either party may terminate the agreement with not less than 30 days of notice to the other party.

As part of the services to be rendered to the company, Red Cloud undertakes to use its best efforts to: (i) maintain a reasonable and consistent bid and offer spread for the company's common stock; (ii) maintain a reasonable board lot size for the bid and the offer of the company's common stock on the TSX Venture Exchange; and (iii) supply liquidity using its own cash in hand. The services will mainly be rendered by Adam Smith, who is acting at arm's length to the company. As of the date of this announcement, Red Cloud, together with Mr. Smith, own securities of the company in the form of common shares.

The engagement of Red Cloud remains subject to the acceptance of the TSX Venture Exchange.

About MedX Health Corp.

MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also imbedded in its products Siametrics, Simsys and MoleMate, which MedX manufactures in its ISO 13485-certified facility. Siametrics, Simsys and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimetres (mm) beneath suspicious moles and lesions in a pain-free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration, and Conformite Europeenne, for use in Canada, the United States, Australia, New Zealand, the European Union and Turkey.

About Red Cloud

Headquartered in Toronto, Ontario, Red Cloud is registered as an Investment Dealer in Ontario, Quebec, Alberta and British Columbia and is a member of the Investment Industry Organization of Canada (IIROC). It is focused on providing unique comprehensive capital market services and innovative financing alternatives to the junior resource sector. Red Cloud was founded by capital markets professionals who designed the firm to service public and private companies. This solution is a comprehensive platform that provides a full range of unconflicted corporate access services. Offering these services as a unified platform provides the ultimate value proposition for issuer clients.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.